U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07423897) titled 'Consumer Health Study Aims to Evaluate the Safety, Tolerability and Impact of ED02 Probiotic Supplement on Gastrointestinal Outcomes' on Feb. 05.
Brief Summary: The Study Team identified Bifidobacterium pseudocatenulatum ED02 as a safe and effective probiotic strain isolated from a healthy human donor. Research by the Study Team indicates that this strain lacks harmful genetic traits and can successfully mitigate infections from hypervirulent pathogens like Klebsiella pneumoniae without adverse effects.
Study Start Date: March 04
Study Type: INTERVENTIONAL
Condition:
Gastrointestinal
Gut Health
Intervention:
DIETARY_SUPPLEMENT...